1. Kocak S, Bumin C, Karayalcin K, Alacayir I, Aribal D. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog. Dig Dis. 1994. 12:62–68.
Article
2. Alvarez C, McFadden DW, Reber HA. Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg. 2000. 24:533–537.
3. Spiliotis J, Vagenas K, Panagopoulos K, Kalfarentzos F. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only. Br J Clin Pract. 1990. 44:616–618.
4. Lugari R, David S, Dall'Argine P, Nicolotti V, Parmeggiani A, Gnudi A, et al. Human pancreatic polypeptide and somatostatin in chronic renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985. 21:614–617.
5. Sirinek KR, O'Dorisio TM, Gaskill HV, Levine BA. Chronic renal failure: effect of HD on gastrointestinal hormones. Am J Surg. 1984. 148:732–735.
6. Sharma AM, Thiede HM, Keller F. Somatostatin-induced hyperkalemia in a patient on hemodialysis. Nephron. 1991. 59:445–448.
Article